retatrutide dosing in trials Guide for Researchers Retatrutide Side Effects Research |

In June 2025, 21 similar complaints were filed in New Jersey state court seeking consolidation into a multicounty litigation

However, a recent clinical study reported that the infusion of exendin 9-39, a GLP-1R antagonist, did not affect ad libitum food intake in post-RYGB patients, although the authors also reported a concomitant increase in plasma levels of the anorexigenic hormone PYY (discussed below), which might offset the orexigenic effect of GLP-1R antagonism (94)

It depends on the concentration

Additionally, the FDA hasnt approved The concurrent use of Mounjaro with other GLP-1 medications is beneficial for people with type 2 diabetes

In the current study, pregnant women with T2DM had higher rates of liveborn babies with major anomalies as compared to the general population